Consumption and cost trends of EGFR TKIs: influences of reimbursement and national price negotiation

BACKGROUND: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have been widely used in the treatment of EGFR mutation non-small-cell lung cancer. The Chinese government has made great efforts to improve the availability and affordability of these drugs. The aim of this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Di, Xie, Jianxiang, Dai, Huizhen, Fang, Wentong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973903/
https://www.ncbi.nlm.nih.gov/pubmed/35365136
http://dx.doi.org/10.1186/s12913-022-07868-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973903/
https://www.ncbi.nlm.nih.gov/pubmed/35365136
http://dx.doi.org/10.1186/s12913-022-07868-9

Ejemplares similares